September 20, 2022
Via: Medical Device NetworkColorectal cancer is second only to lung cancer as the leading cause of cancerous deaths. According to the International Agency for Research on Cancer, the estimated annual number of deaths due to colon cancer is projected to nearly double from […]
August 19, 2021
Via: ScienceDaily HealthCommon blood-pressure drugs may improve survival for patients with colorectal cancer, a new study suggests. After reviewing outcomes of almost 14,000 patients with colorectal cancer, researchers determined that ACE inhibitors, beta-blockers and thiazide diuretics were all associated with decreased mortality. […]
December 30, 2020
Via: MedPageTodayA majority of patients with colorectal cancer found at least one benefit from their diagnosis. (Fox Chase Cancer Center) Half of disruptions in ongoing clinical trials resulted from slow patient enrollment. (GlobalData) Laboratory studies suggested that a drug used to […]
June 16, 2020
Via: The Medical NewsA collaborative study by research groups from the VIB-UGent Center for Inflammation Research and Ghent University uncovered a new mechanism causing colorectal cancer. The researchers found that abnormal expression of the protein Zeb2 affects the integrity of the intestinal wall […]
April 19, 2019
Via: Medical News TodayA clinical trial called SUNSHINE has found that large doses of vitamin D could significantly slow down the progression of metastatic colorectal cancer. Dr. Kimmie Ng, director of clinical research at Dana-Farber’s Gastrointestinal Cancer Treatment Center in Boston, MA, says […]
January 8, 2019
Via: Medical News TodayThis makes it the third most common cancer that medical professionals detect in both men and women. Colorectal cancer, which doctors also refer to as bowel cancer, is responsible for more than 50,000 deaths each year in the U.S. If […]
July 26, 2018
Via: The Medical NewsCellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells (CTC). The patents cover the entire detection workflow, […]
January 5, 2018
Via: The Medical NewsAn urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn’t help most patients. Now, two research groups from Dana-Farber Cancer Institute have independently discovered a genetic mechanism in cancer cells that influences whether […]